Eye scan to help identify heart artery disease
Part of Heart & circulation clinical trials.
This trial tests whether a special eye imaging scan (fundus OCTA) can help identify “CMD,” a type of heart-related blood flow problem. You may be eligible if you already had coronary angiography and your coronary narrowing is less than 50%.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You had coronary angiography at Peking University First Hospital
- Your coronary angiography showed less than 50% artery narrowing
- You can provide complete basic health information and sign consent
- Your eye health must not have serious problems that block clear eye imaging
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether images of the back of your eye and certain substances in your blood can help identify people at high risk for heart disease. If you're having tests for chest pain or other heart concerns, this research may help improve early detection.
This trial tests a special wireless pressure catheter to see how well the tiny blood vessels in the heart are working. It may help people who have chest pain but don't have major blockages in their main heart arteries.
This study tests if a non-invasive eye scan (OCT-A) can detect changes in tiny blood vessels in the retina of people with chest pain caused by problems with the heart's small arteries (microvascular angina). If it works, it could be a simpler way to diagnose this condition.
This study looks at special eye scans (OCT) to see if they can help doctors predict how heart patients will do. It also uses artificial intelligence to analyze the scans. If you have had this type of scan during a heart procedure, you might be able to join.
This study uses a special eye scan (OCTA) to look at tiny blood vessels in the eye and see if they can help predict outcomes for people who had a heart attack without blocked arteries (MINOCA). It compares these patients to others with typical heart attacks and healthy people.
This study is testing a new way to measure blood flow in the heart's small arteries (called caIMR) to help doctors decide on the best treatment for people with certain types of chest pain or suspected reduced blood flow. It is for patients who do not have major blockages but might still have issues in the small vessels or along a long segment of the artery.
Hear when a new Coronary Microvascular Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.